Bio-Techne CFO Departs; New Directors Appointed
Ticker: TECH · Form: 8-K · Filed: Mar 4, 2025 · CIK: 842023
| Field | Detail |
|---|---|
| Company | Bio-Techne Corp (TECH) |
| Form Type | 8-K |
| Filed Date | Mar 4, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-change, board-composition, personnel
TL;DR
CFO out, interim CFO in, two new board members for Bio-Techne.
AI Summary
Bio-Techne Corporation announced on February 26, 2025, the departure of its Chief Financial Officer, David A. Christenson. The company has appointed James M. Kohl as the interim CFO. Additionally, the company elected two new directors, Dr. Steven G. Roell and Ms. Susan L. Roth, to its Board of Directors.
Why It Matters
Changes in key executive positions and board composition can signal shifts in company strategy or financial oversight, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in CFO and board composition can introduce uncertainty regarding future financial strategy and governance.
Key Players & Entities
- Bio-Techne Corporation (company) — Registrant
- David A. Christenson (person) — Departing Chief Financial Officer
- James M. Kohl (person) — Interim Chief Financial Officer
- Dr. Steven G. Roell (person) — Newly Elected Director
- Ms. Susan L. Roth (person) — Newly Elected Director
- February 26, 2025 (date) — Date of earliest event reported
FAQ
Who has been appointed as the interim Chief Financial Officer?
James M. Kohl has been appointed as the interim Chief Financial Officer.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on February 26, 2025.
Who are the new directors elected to the Board?
Dr. Steven G. Roell and Ms. Susan L. Roth have been elected as new directors.
What was the previous name of Bio-Techne Corporation?
The former company name was TECHNE CORP /MN/.
In which state is Bio-Techne Corporation incorporated?
Bio-Techne Corporation is incorporated in Minnesota.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 4, 2025 by David A. Christenson regarding BIO-TECHNE Corp (TECH).